6.785

1.38% -0.095

Mannkind Corp (MNKD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MNKD? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$6.88

Offen:

$6.89

24-Stunden-Volumen:

837.67K

Relative Volume:

0.34

Marktkapitalisierung:

$1.94B

Einnahmen:

$248.37M

Nettoeinkommen (Verlust:

$11.74M

KGV:

-35.71

EPS:

-0.19

Netto-Cashflow:

$18.24M

1W Leistung:

-3.35%

1M Leistung:

+2.49%

6M Leistung:

+43.14%

1J Leistung:

+82.88%

1-Tages-Spanne:

$6.74

$6.935

1-Wochen-Bereich:

$6.62

$7.07

52-Wochen-Spanne:

$3.17

$7.63

Mannkind Corp Stock (MNKD) Company Profile

Firmenname

Mannkind Corp

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

818-661-5000

Adresse

1 CASPER STREET, DANBURY, CA

Mitarbeiter

414

Twitter

@MannKindCorp

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

MNKD's Discussions on Twitter

Vergleichen Sie MNKD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MNKD	6.785	1.94B	248.37M	11.74M	18.24M	-0.19
VRTX	446.09	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	741.51	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.05	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.35	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.05	24.49B	3.30B	-501.07M	1.03B	11.54

Mannkind Corp Stock (MNKD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-10-10	Eingeleitet	Wedbush	Outperform
2021-05-14	Eingeleitet	RBC Capital Mkts	Sector Perform
2019-12-24	Eingeleitet	Oppenheimer	Outperform
2019-10-25	Eingeleitet	Cantor Fitzgerald	Overweight
2019-05-14	Eingeleitet	BTIG Research	Buy
2019-03-04	Eingeleitet	SVB Leerink	Outperform
2019-02-22	Eingeleitet	SVB Leerink	Outperform
2018-02-28	Herabstufung	Maxim Group	Hold → Sell
2017-11-01	Herabstufung	Maxim Group	Buy → Hold
2017-10-10	Eingeleitet	H.C. Wainwright	Buy
2017-10-06	Bestätigt	Maxim Group	Buy
2017-08-11	Eingeleitet	Maxim Group	Buy
2016-05-10	Bestätigt	Piper Jaffray	Underweight
2016-05-10	Bestätigt	RBC Capital Mkts	Underperform
2016-01-06	Bestätigt	Piper Jaffray	Underweight
2016-01-06	Bestätigt	RBC Capital Mkts	Underperform
2015-11-04	Herabstufung	RBC Capital Mkts	Outperform → Underperform
2015-09-09	Herabstufung	Piper Jaffray	Neutral → Underweight
2015-08-03	Bestätigt	RBC Capital Mkts	Outperform
2015-05-11	Herabstufung	JP Morgan	Neutral → Underweight
2015-05-11	Bestätigt	MLV & Co	Hold
2015-04-16	Bestätigt	RBC Capital Mkts	Outperform

Alle ansehen

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

01:19 AM

MannKind (STU:NNFN) Inventories, Raw Materials & Components : €5.8 Mil (As of Sep. 2024) - GuruFocus.com

01:19 AM

Nov 20, 2024

MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN

Nov 20, 2024

Nov 19, 2024

MannKind Corp director Steven Binder sells $456,563 in stock - Investing.com

Nov 19, 2024

Nov 11, 2024

Insulin Pump Market Report 2024-2035, Featuring Profiles of Leading Players Including Beta Bionics, CeQur, EOFlow, Insulet, LA Roche, MannKind, Medtronic, Medtrum Technologies and MicroPort - Yahoo Finance

Nov 11, 2024

Nov 09, 2024

MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 09, 2024

Insider Sale: Chief People & Workpl Officer Stuart Tross Sells 5 - GuruFocus.com

Nov 09, 2024

Nov 08, 2024

MannKind Corp's chief people officer Stuart Tross sells $403,700 in stock - Investing.com Australia

Nov 08, 2024

Earnings call: MannKind sees growth and pipeline progress in Q3 2024 - Investing.com

Nov 08, 2024

MannKind Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024

Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Quantisnow

Nov 08, 2024